about
OCT demonstrating neoatherosclerosis as part of the continuous process of coronary artery diseaseOptical Coherence Tomography: Potential Clinical Applications.Safety of optical coherence tomography in daily practice: a comparison with intravascular ultrasound.Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experienceInfluence of the Accuracy of Angiography-Based Reconstructions on Velocity and Wall Shear Stress Computations in Coronary Bifurcations: A Phantom Study.Quantification of fibrous cap thickness in intracoronary optical coherence tomography with a contour segmentation method based on dynamic programming.First-in-man assessment of plaque rupture by polarization-sensitive optical frequency domain imaging in vivo.Fusion of fibrous cap thickness and wall shear stress to assess plaque vulnerability in coronary arteries: a pilot study.Percutaneous coronary intervention in chronic stable angina.Vulnerable atherosclerotic plaque: from the basic research laboratory to the clinic.Optical coherence tomography for evaluation of coronary stents in vivo.Vulnerable plaque imaging: updates on new pathobiological mechanisms.Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.The -174 G>C Interleukin-6 Gene Polymorphism is Associated with Angiographic Progression of Coronary Artery Disease over a 4-Year Period.Automated characterisation of lipid core plaques in vivo by quantitative optical coherence tomography tissue type imaging.Intracoronary optical coherence tomography: Clinical and research applications and intravascular imaging software overview.Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry.Everolimus-eluting bioresorbable vascular scaffolds implanted in coronary bifurcation lesions: Impact of polymeric wide struts on side-branch impairment.Differential thrombotic prolapse burden in either bioresorbable vascular scaffolds or metallic stents implanted during acute myocardial infarction: The snowshoe effect: Insights from the maximal footprint analysis.Are BVS suitable for ACS patients? Support from a large single center real live registry.Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI fiVery late bioresorbable scaffold thrombosis after discontinuation of dual antiplatelet therapy.Bioresorbable scaffold in myocardial infarction: has the time come?Chemical denervation of the renal artery by vincristine in swine. A new catheter based technique.The impact of Fourier-Domain optical coherence tomography catheter induced motion artefacts on quantitative measurements of a PLLA-based bioresorbable scaffold.Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study.Contour segmentation of the intima, media, and adventitia layers in intracoronary OCT images: application to fully automatic detection of healthy wall regions.A novel hybrid approach for reconstruction of coronary bifurcations using angiography and OCT.Association of stent-induced changes in coronary geometry with late stent failure: Insights from three-dimensional quantitative coronary angiographic analysis.The OPTIS Integrated System: real-time, co-registration of angiography and optical coherence tomography.Expression of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Human Epicardial and Intramyocardial Coronary Arteries of Male Patients Undergoing Coronary Artery Bypass Grafting.Qualitative and quantitative evaluation of dynamic changes in non-culprit coronary atherosclerotic lesion morphology. A longitudinal OCT study.Everolimus-eluting bioresorbable vascular scaffold implantation in Kawasaki disease: serial OCT observation.Impact of plaque type and side branch geometry on side branch compromise after provisional stent implantation: a simulation study.Is it safe to implant bioresorbable scaffolds in ostial side-branch lesions? Impact of 'neo-carina' formation on main-branch flow pattern. Longitudinal clinical observations.Visualization of extensive intraplaque neovascularization by optical coherence tomography.Optical coherence tomography guided treatment of recurrent drug-eluting stent failure using drug-eluting balloon.An Unusual Complication After Bioresorbable Scaffold Implantation: Visualization of Intramural Hematoma by Optical Coherence Tomography.New insights by optical coherence tomography into the differences and similarities of culprit ruptured plaque morphology in non-ST-elevation myocardial infarction and ST-elevation myocardial infarction.Inhibition of Aortic Valve Calcification by Local Delivery of Zoledronic Acid-an Experimental Study.
P50
Q26799738-F9987A85-DE56-44ED-8235-07F7186668D8Q30465775-DA741251-A937-4EA1-8CDF-CC0038BACF65Q34518899-AD7CBD0C-0634-4942-BC3F-E18F329BB0F5Q35787354-CEAE4ED3-F9B1-4548-8D2F-C74086AD633DQ35874573-3D482FCA-F635-4069-821B-65D56276183BQ36038083-EE3A78BC-C25B-436F-A8DD-AEF20CC1F786Q37030545-80B24E52-24F2-4B5F-B7CE-68BFD3B98079Q37277492-C5DF4CA5-AC07-4B58-96B5-D45A88932967Q37726807-72792F0B-90A8-40E9-86F2-1846C5176034Q38065810-B995FADB-D93C-421E-A7E4-A34C528D67C1Q38101964-EBAB1ACC-7D31-49C8-B0E7-8B3241F692B1Q38595328-86E79410-3621-4B73-B5C9-F4DE72848244Q38813631-6F87DE24-BD17-4966-9279-11AEB677C990Q38954932-EC5F1C6A-B979-43A0-A8A6-CFDC92236428Q39081037-D616F269-31BF-4988-BE6A-E73015C665A4Q39097251-C0D00D8C-431D-43D5-BAD3-91157540378DQ39541410-E3216451-862C-4B44-AF43-DDF65C2A5AF4Q39596121-8121D4B6-19D6-4146-B5D6-129471827ADEQ39618283-5B501457-AE0B-47FF-B66E-26649BEFA74DQ39731228-1529F477-45DD-431D-9F07-D696A98BE9F9Q39770656-867054DB-EFF9-4C39-B1BC-A84B2311B006Q41966087-CBEB222E-6EAD-4529-8407-73E8A38B6C67Q43752928-F0DA7E78-9A1A-4136-9D71-9C39F6E03FAEQ44248527-F7DB0A60-15D6-425C-8654-73F55608CFBFQ45348831-9E92D7E0-EDDF-4DFB-BE88-0E4924F9D7E8Q45802485-2CA4045A-C193-493A-8397-541886521394Q45946289-FC03445D-6D53-41B4-851C-FE1BFB1E7A8DQ47635936-C2C2BD39-8670-4BB9-A2AE-6A924FCF1ADEQ48107353-C43DCEFA-221F-458F-AA6A-158535AC8D31Q49041429-DB17CC94-BB5F-46FF-B4DC-B532C8136DD4Q49967267-48665942-D8AC-4970-B26E-6B84ABFAA0E3Q50048035-A6F477E0-0643-4C0F-BCDF-82AFCD7F7391Q50144846-C2835BC5-27B7-4F16-B0B6-C67837E9FDBEQ50732967-65BB32F4-33B2-4C8E-B084-7BED0593C9ADQ51005646-9B25CCDF-968F-43E8-BAC9-3F40FF6045C9Q51017017-39890479-C58D-414D-9F35-FC47A5406802Q51253646-36BA4197-9763-43B2-BD73-36F9BF4368F2Q51801242-3F8D8E87-25AC-4C06-87D7-5728ABD7A2EFQ52612073-53ABB2E5-9EF8-4CB3-9A77-5EC690DC5B7AQ52628773-61AF9B81-4017-421F-8235-474083E177AF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonios Karanasos
@ast
Antonios Karanasos
@en
Antonios Karanasos
@es
Antonios Karanasos
@nl
type
label
Antonios Karanasos
@ast
Antonios Karanasos
@en
Antonios Karanasos
@es
Antonios Karanasos
@nl
prefLabel
Antonios Karanasos
@ast
Antonios Karanasos
@en
Antonios Karanasos
@es
Antonios Karanasos
@nl
P106
P1153
26026341500
P21
P31
P496
0000-0001-8052-6739